Jeffrey B. Arterburn - Publications

Affiliations: 
1990 University of Arizona, Tucson, AZ 
 1992- Chemistry and Biochemistry New Mexico State University, Las Cruces, NM, United States 
Area:
small molecular probes, imaging agents, anticancer and antiviral drugs.
Website:
https://chemistry.nmsu.edu/people/faculty/jeffrey-b-arterburn/

91 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Scroggs SLP, Gass JT, Chinnasamy R, Widen SG, Azar SR, Rossi SL, Arterburn JB, Vasilakis N, Hanley KA. Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness. Virology. 552: 94-106. PMID 33120225 DOI: 10.1016/j.virol.2020.09.004  1
2020 Scroggs SLP, Andrade CC, Chinnasamy R, Azar SR, Schirtzinger EE, Garcia EI, Arterburn JB, Hanley KA, Rossi SL. Old Drugs with New Tricks: Efficacy of Fluoroquinolones to Suppress Replication of Flaviviruses. Viruses. 12. PMID 32933138 DOI: 10.3390/V12091022  1
2020 Sharma G, Hu C, Staquicini DI, Brigman JL, Liu M, Mauvais-Jarvis F, Pasqualini R, Arap W, Arterburn JB, Hathaway HJ, Prossnitz ER. Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes. Science Translational Medicine. 12. PMID 31996464 DOI: 10.1126/Scitranslmed.Aau5956  1
2020 Ahmadian R, Sheak JR, Weise-Cross L, Jernigan NL, Arterburn JB, Prossnitz ER, Snow JB, Resta TC. GPER Contributes to the Development of Pulmonary Hypertension in Female Rats The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.07087  0.01
2019 Revankar CM, Bologa CG, Pepermans RA, Sharma G, Petrie WK, Alcon SN, Field AS, Ramesh C, Parker MA, Savchuk NP, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling. Cell Chemical Biology. PMID 31706983 DOI: 10.1016/J.Chembiol.2019.10.009  1
2019 Vargas-Medrano J, Segura-Ulate I, Yang B, Chinnasamy R, Arterburn JB, Perez RG. FTY720-mitoxy reduces toxicity associated with α-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures. Neuropharmacology. 107701. PMID 31291595 DOI: 10.1016/J.Neuropharm.2019.107701  1
2019 Sapkota RR, Jarvis JM, Schaub TM, Talipov MR, Arterburn JB. Bimolecular Cross-Metathesis of a Tetrasubstituted Alkene with Allylic Sulfones. Chemistryopen. 8: 201-205. PMID 30815328 DOI: 10.1002/Open.201800296  0.12
2016 Meyer MR, Fredette NC, Daniel C, Sharma G, Amann K, Arterburn JB, Barton M, Prossnitz ER. Obligatory role for GPER in cardiovascular aging and disease. Science Signaling. 9: ra105. PMID 27803283 DOI: 10.1126/Scisignal.Aag0240  1
2016 Enoru JO, Yang B, Krishnamachari S, Villanueva E, DeMaio W, Watanyar A, Chinnasamy R, Arterburn JB, Perez RG. Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy. Plos One. 11: e0162162. PMID 27611691 DOI: 10.1371/Journal.Pone.0162162  1
2015 Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, Amann K, Arterburn JB, Barton M, Prossnitz ER. Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis. Scientific Reports. 5: 13510. PMID 26373621 DOI: 10.1038/Srep13510  1
2015 Prossnitz ER, Arterburn JB. International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators. Pharmacological Reviews. 67: 505-40. PMID 26023144 DOI: 10.1124/Pr.114.009712  1
2014 Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, Amann K, Arterburn JB, Barton M, Prossnitz ER. G protein-coupled estrogen receptor protects from atherosclerosis. Scientific Reports. 4: 7564. PMID 25532911 DOI: 10.1038/Srep07564  1
2014 Vargas-Medrano J, Krishnamachari S, Villanueva E, Godfrey WH, Lou H, Chinnasamy R, Arterburn JB, Perez RG. Novel FTY720-Based Compounds Stimulate Neurotrophin Expression and Phosphatase Activity in Dopaminergic Cells. Acs Medicinal Chemistry Letters. 5: 782-6. PMID 25050165 DOI: 10.1021/Ml500128G  1
2014 Nayak TK, Ramesh C, Hathaway HJ, Norenberg JP, Arterburn JB, Prossnitz ER. GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding. Molecular Cancer Research : McR. 12: 1635-43. PMID 25030373 DOI: 10.1158/1541-7786.Mcr-14-0289  1
2014 Hapuarachchige S, Bryant BK, Arterburn JB. Synthesis of (pyridin-2-yl)hydrazone rhenium(i) tricarbonyl complexes that exhibit ph-sensitive fluorescence Chemistry of Heterocyclic Compounds. 50: 254-263. DOI: 10.1007/S10593-014-1469-4  1
2013 Petrie WK, Dennis MK, Hu C, Dai D, Arterburn JB, Smith HO, Hathaway HJ, Prossnitz ER. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstetrics and Gynecology International. 2013: 472720. PMID 24379833 DOI: 10.1155/2013/472720  1
2013 Jang EJ, Seok YM, Arterburn JB, Olatunji LA, Kim IK. GPER-1 agonist G1 induces vasorelaxation through activation of epidermal growth factor receptor-dependent signalling pathway. The Journal of Pharmacy and Pharmacology. 65: 1488-99. PMID 24028616 DOI: 10.1111/Jphp.12113  1
2013 Brailoiu GC, Benamar K, Arterburn JB, Gao E, Rabinowitz JE, Koch WJ, Brailoiu E. Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation. The Journal of Physiology. 591: 4223-35. PMID 23878371 DOI: 10.1113/Jphysiol.2013.257204  1
2013 Brailoiu GC, Arterburn JB, Oprea TI, Chitravanshi VC, Brailoiu E. Bradycardic effects mediated by activation of G protein-coupled estrogen receptor in rat nucleus ambiguus. Experimental Physiology. 98: 679-91. PMID 23104934 DOI: 10.1113/Expphysiol.2012.069377  1
2013 Stailey JE, Hapuarachchige S, Ramesh C, Shrestha S, Wimbley AM, Shuster CB, Arterburn JB, Houston KD. Abstract 2237: Synthesis and characterization of novel, membrane permeable estradiol fluorophores that maintain estrogenic activity. Cancer Research. 73: 2237-2237. DOI: 10.1158/1538-7445.Am2013-2237  1
2012 Burai R, Ramesh C, Nayak TK, Dennis MK, Bryant BK, Prossnitz ER, Arterburn JB. Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30. Plos One. 7: e46861. PMID 23077529 DOI: 10.1371/Journal.Pone.0046861  1
2012 Deliu E, Brailoiu GC, Arterburn JB, Oprea TI, Benamar K, Dun NJ, Brailoiu E. Mechanisms of G protein-coupled estrogen receptor-mediated spinal nociception. The Journal of Pain : Official Journal of the American Pain Society. 13: 742-54. PMID 22858342 DOI: 10.1016/J.Jpain.2012.05.011  1
2011 Tica AA, Dun EC, Tica OS, Gao X, Arterburn JB, Brailoiu GC, Oprea TI, Brailoiu E. G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium. American Journal of Physiology. Cell Physiology. 301: C1262-9. PMID 21865584 DOI: 10.1152/Ajpcell.00501.2010  1
2011 Rodriguez D, Ramesh C, Henson LH, Wilmeth L, Bryant BK, Kadavakollu S, Hirsch R, Montoya J, Howell PR, George JM, Alexander D, Johnson DL, Arterburn JB, Shuster CB. Synthesis and characterization of tritylthioethanamine derivatives with potent KSP inhibitory activity. Bioorganic & Medicinal Chemistry. 19: 5446-53. PMID 21855351 DOI: 10.1016/J.Bmc.2011.07.054  1
2011 Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, Oprea TI, Yamaguchi Y, Hayashi S, Sklar LA, Hathaway HJ, Arterburn JB, Prossnitz ER. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. The Journal of Steroid Biochemistry and Molecular Biology. 127: 358-66. PMID 21782022 DOI: 10.1016/J.Jsbmb.2011.07.002  1
2011 Hapuarachchige S, Montaño G, Ramesh C, Rodriguez D, Henson LH, Williams CC, Kadavakkollu S, Johnson DL, Shuster CB, Arterburn JB. Design and synthesis of a new class of membrane-permeable triazaborolopyridinium fluorescent probes. Journal of the American Chemical Society. 133: 6780-90. PMID 21473622 DOI: 10.1021/Ja2005175  1
2011 Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterburn JB, Chorazyczewski J, Feldman RD. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension. 57: 442-51. PMID 21242460 DOI: 10.1161/Hypertensionaha.110.161653  1
2010 Nayak TK, Dennis MK, Ramesh C, Burai R, Atcher RW, Sklar LA, Norenberg JP, Hathaway HJ, Arterburn JB, Prossnitz ER. Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents. Acs Chemical Biology. 5: 681-90. PMID 20486699 DOI: 10.1021/Cb1000636  1
2010 McDowell M, Gonzales SR, Kumarapperuma SC, Jeselnik M, Arterburn JB, Hanley KA. A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro. Antiviral Research. 87: 78-80. PMID 20416341 DOI: 10.1016/J.Antiviral.2010.04.007  1
2010 Burai R, Ramesh C, Shorty M, Curpan R, Bologa C, Sklar LA, Oprea T, Prossnitz ER, Arterburn JB. Highly efficient synthesis and characterization of the GPR30-selective agonist G-1 and related tetrahydroquinoline analogs. Organic & Biomolecular Chemistry. 8: 2252-9. PMID 20401403 DOI: 10.1039/C001307B  1
2010 Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Research. 70: 1184-94. PMID 20086172 DOI: 10.1158/0008-5472.Can-09-3068  1
2010 Ramesh C, Nayak TK, Burai R, Dennis MK, Hathaway HJ, Sklar LA, Prossnitz ER, Arterburn JB. Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30. Journal of Medicinal Chemistry. 53: 1004-14. PMID 20041667 DOI: 10.1021/Jm9011802  1
2009 Arterburn JB, Oprea TI, Prossnitz ER, Edwards BS, Sklar LA. Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30. Current Topics in Medicinal Chemistry. 9: 1227-36. PMID 19807662 DOI: 10.2174/156802609789753608  1
2009 Chung DH, Strouse JJ, Sun Y, Arterburn JB, Parker WB, Jonsson CB. Synthesis and anti-Hantaan virus activity of N(1)-3-fluorophenyl-inosine. Antiviral Research. 83: 80-5. PMID 19501259 DOI: 10.1016/J.Antiviral.2009.03.007  1
2009 Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, et al. In vivo effects of a GPR30 antagonist. Nature Chemical Biology. 5: 421-7. PMID 19430488 DOI: 10.1038/Nchembio.168  1
2009 Dun SL, Brailoiu GC, Gao X, Brailoiu E, Arterburn JB, Prossnitz ER, Oprea TI, Dun NJ. Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia. Journal of Neuroscience Research. 87: 1610-9. PMID 19125412 DOI: 10.1002/Jnr.21980  1
2009 Young SM, Bologa CM, Fara D, Bryant BK, Strouse JJ, Arterburn JB, Ye RD, Oprea TI, Prossnitz ER, Sklar LA, Edwards BS. Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 75: 253-63. PMID 18785269 DOI: 10.1002/Cyto.A.20645  1
2008 Nayak TK, Hathaway HJ, Ramesh C, Arterburn JB, Dai D, Sklar LA, Norenberg JP, Prossnitz ER. Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 978-86. PMID 18483091 DOI: 10.2967/Jnumed.107.048546  1
2008 Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB. The ins and outs of GPR30: a transmembrane estrogen receptor. The Journal of Steroid Biochemistry and Molecular Biology. 109: 350-3. PMID 18406603 DOI: 10.1016/J.Jsbmb.2008.03.006  1
2008 Chung DH, Kumarapperuma SC, Sun Y, Li Q, Chu YK, Arterburn JB, Parker WB, Smith J, Spik K, Ramanathan HN, Schmaljohn CS, Jonsson CB. Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Research. 79: 19-27. PMID 18394724 DOI: 10.1016/J.Antiviral.2008.02.003  1
2008 Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annual Review of Physiology. 70: 165-90. PMID 18271749 DOI: 10.1146/Annurev.Physiol.70.113006.100518  1
2008 Prossnitz ER, Sklar LA, Oprea TI, Arterburn JB. GPR30: a novel therapeutic target in estrogen-related disease. Trends in Pharmacological Sciences. 29: 116-23. PMID 18262661 DOI: 10.1016/J.Tips.2008.01.001  1
2008 George O, Bryant BK, Chinnasamy R, Corona C, Arterburn JB, Shuster CB. Bisphenol A directly targets tubulin to disrupt spindle organization in embryonic and somatic cells. Acs Chemical Biology. 3: 167-79. PMID 18225860 DOI: 10.1021/Cb700210U  1
2008 Arterburn J, Kumarapperuma S, Jeselnik M, Chung D, Sun Y, Parker W, Chu YK, Jonsson C. Design, Synthesis and Evaluation of 3-Ethynyl-Azole Nucleosides with Antiviral Activity Against Hantaviruses Antiviral Research. 78: A33. DOI: 10.1016/J.Antiviral.2008.01.057  0.01
2007 Chung DH, Sun Y, Parker WB, Arterburn JB, Bartolucci A, Jonsson CB. Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus. Journal of Virology. 81: 11722-9. PMID 17699579 DOI: 10.1128/Jvi.00874-07  1
2007 Revankar CM, Mitchell HD, Field AS, Burai R, Corona C, Ramesh C, Sklar LA, Arterburn JB, Prossnitz ER. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. Acs Chemical Biology. 2: 536-44. PMID 17655271 DOI: 10.1021/Cb700072N  1
2007 Kumarapperuma SC, Sun Y, Jeselnik M, Chung K, Parker WB, Jonsson CB, Arterburn JB. Structural effects on the phosphorylation of 3-substituted 1-beta-D-ribofuranosyl-1,2,4-triazoles by human adenosine kinase. Bioorganic & Medicinal Chemistry Letters. 17: 3203-7. PMID 17379518 DOI: 10.1016/J.Bmcl.2007.03.018  1
2007 Prossnitz ER, Arterburn JB, Sklar LA. GPR30: A G protein-coupled receptor for estrogen. Molecular and Cellular Endocrinology. 265: 138-42. PMID 17222505 DOI: 10.1016/J.Mce.2006.12.010  1
2006 Prossnitz ER, Arterburn JB, Edwards BS, Sklar LA, Oprea TI. Steroid-binding G-protein-coupled receptors: new drug discovery targets for old ligands. Expert Opinion On Drug Discovery. 1: 137-50. PMID 23495797 DOI: 10.1517/17460441.1.2.137  1
2006 Poria RB, Norenberg JP, Anderson TL, Erion J, Wagner CR, Arterburn JB, Larson RS. Characterization of a radiolabeled small molecule targeting leukocyte function-associated antigen-1 expression in lymphoma and leukemia. Cancer Biotherapy & Radiopharmaceuticals. 21: 418-26. PMID 17105416 DOI: 10.1089/Cbr.2006.21.418  1
2006 Ramesh C, Bryant B, Nayak T, Revankar CM, Anderson T, Carlson KE, Katzenellenbogen JA, Sklar LA, Norenberg JP, Prossnitz ER, Arterburn JB. Linkage effects on binding affinity and activation of GPR30 and estrogen receptors ERalpha/beta with tridentate pyridin-2-yl hydrazine tricarbonyl-Re/(99m)Tc(I) chelates. Journal of the American Chemical Society. 128: 14476-7. PMID 17090028 DOI: 10.1021/Ja066360P  1
2006 Corona C, Bryant BK, Arterburn JB. Synthesis of a biotin-derived alkyne for pd-catalyzed coupling reactions. Organic Letters. 8: 1883-6. PMID 16623575 DOI: 10.1021/Ol060458R  1
2006 Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nature Chemical Biology. 2: 207-12. PMID 16520733 DOI: 10.1038/Nchembio775  1
2005 Pietras RJ, Levin ER, Szego CM, Prossnitz ER, Revankar CM, Arterburn JB, Sklar LA. Estrogen receptors and cell signalling [2] (multiple letters) Science. 310: 51-53. PMID 16210518 DOI: 10.1126/Science.310.5745.51  1
2005 Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (New York, N.Y.). 307: 1625-30. PMID 15705806 DOI: 10.1126/Science.1106943  1
2005 Jonsson CB, Milligan BG, Arterburn JB. Potential importance of error catastrophe to the development of antiviral strategies for hantaviruses. Virus Research. 107: 195-205. PMID 15649565 DOI: 10.1016/J.Virusres.2004.11.009  1
2005 Strouse JJ, Jeselnik M, Tapaha F, Jonsson CB, Parker WB, Arterburn JB. Copper catalyzed arylation with boronic acids for the synthesis of N 1-aryl purine nucleosides Tetrahedron Letters. 46: 5699-5702. DOI: 10.1016/J.Tetlet.2005.06.083  1
2005 Strouse JJ, Ješelnik M, Arterburn JB. Applications of boronic acids in selective C-C and C-N arylation of purines Acta Chimica Slovenica. 52: 187-199.  1
2003 Arterburn JB, Corona C, Rao KV, Carlson KE, Katzenellenbogen JA. Synthesis of 17-alpha-substituted estradiol-pyridin-2-yl hydrazine conjugates as effective ligands for labeling with Alberto's complex fac-[Re(OH2)3(CO)3]+ in water. The Journal of Organic Chemistry. 68: 7063-70. PMID 12946150 DOI: 10.1021/Jo034780G  1
2003 Arterburn JB, Bryant BK, Chen D. Synthesis of (pyridin-2-yl)hydrazine conjugates as bifunctional chelates using the Suzuki-Miyaura reaction. Chemical Communications (Cambridge, England). 1890-1. PMID 12932018 DOI: 10.1039/B304153K  1
2002 Arterburn JB, Liu M, Perry MC. Polystyrene-supported (catecholato)oxorhenium complexes: Catalysts for alcohol oxidation with DMSO and for deoxygenation of epoxides to alkenes with triphenylphosphine Helvetica Chimica Acta. 85: 3225-3236. DOI: 10.1002/1522-2675(200210)85:10<3225::Aid-Hlca3225>3.0.Co;2-H  1
2001 Arterburn JB, Rao KV, Ramdas R, Dible BR. Catalytic amination of 2-substituted pyridines with hydrazine derivatives. Organic Letters. 3: 1351-4. PMID 11348232 DOI: 10.1021/Ol015731Y  1
2001 Arterburn JB, Pannala M, Gonzalez AM. Catalytic amination of 5-iodouracil derivatives Tetrahedron Letters. 42: 1475-1477. DOI: 10.1016/S0040-4039(00)02315-7  1
2001 Arterburn JB. Selective oxidation of secondary alcohols Tetrahedron. 57: 9765-9788. DOI: 10.1016/S0040-4020(01)01009-2  1
2001 Bernard JG, Bauer E, Richards MP, Arterburn JB, Chamberlin RM. Catalytic reduction of pertechnetate (99TcO4 -) in simulated alkaline nuclear wastes Radiochimica Acta. 89: 59-61.  1
2000 Arterburn JB, Rao KV, Perry MC. Solid-Supported Hydrazine Substrate For Labeling Estradiol Ligands with Rhenium. Angewandte Chemie (International Ed. in English). 39: 771-772. PMID 10760864 DOI: 10.1002/(Sici)1521-3757(20000218)112:4<787::Aid-Ange787>3.0.Co;2-G  1
2000 Arterburn JB, Rao KV, Goreham DM, Valenzuela MV, Holguin MS, Hall KA, Ott KC, Bryan JC. Functionalized rhenium(V) organoimido complexes as potential radiopharmaceuticals. 2. Synthesis, structural characterization, and reactivity of N-succinimidyl ester derivatives with amines Organometallics. 19: 1789-1795. DOI: 10.1021/Om990929W  1
2000 Arterburn JB, Rao KV, Perry MC. Novel 17α-ethynylestradiol derivatives: Sonogashira couplings using unprotected phenylhydrazines Tetrahedron Letters. 41: 839-842. DOI: 10.1016/S0040-4039(99)02205-4  1
2000 Arterburn JB, Pannala M, Gonzalez AM, Chamberlin RM. Palladium-catalyzed transfer hydrogenation in alkaline aqueous medium Tetrahedron Letters. 41: 7847-7849. DOI: 10.1016/S0040-4039(00)01365-4  1
1999 Arterburn JB, Perry MC. Selective rhenium-catalyzed oxidation of secondary alcohols with methyl sulfoxide in the presence of ethylene glycol, a convenient one-pot synthesis of ketals. Organic Letters. 1: 769-71. PMID 16118882 DOI: 10.1021/Ol990755E  1
1998 Bryan JC, Perry MC, Arterburn JB. Trichlorooxo(triphenylphosphine)(triphenylphosphine oxide)rhenium(V) Acta Crystallographica Section C: Crystal Structure Communications. 54: 1607-1608. DOI: 10.1107/S010827019800818X  1
1997 Arterburn JB, Hall KA, Fogarty IM, Goreham DM, Bryan JC, Ott KC. Radiopharmaceutical Design Using Novel Re-188 Imido Complexes Radiochimica Acta. 79: 119-121. DOI: 10.1524/Ract.1997.79.2.119  1
1997 Arterburn JB, Perry MC, Nelson SL, Dible BR, Holguin MS. Rhenium-catalyzed oxidation of thiols and disulfides with sulfoxides Journal of the American Chemical Society. 119: 9309-9310. DOI: 10.1021/Ja972013R  1
1997 Arterburn JB, Perry MC. Rhenium catalyzed sulfurization of phosphorus(III) compounds with thiiranes: New reagents for phosphorothioate ester synthesis Tetrahedron Letters. 38: 7701-7704. DOI: 10.1016/S0040-4039(97)10029-6  1
1997 Dilworth JR, Hussain W, Hutson AJ, Jones CJ, McQuillan FS, Mayer JM, Arterburn JB. Tetrahalo oxorhenate anions Inorganic Syntheses. 31: 257-262.  1
1996 Arterburn JB, Nelson SL. Rhenium-catalyzed oxidation of sulfides with phenyl sulfoxide Journal of Organic Chemistry. 61: 2260-2261. DOI: 10.1021/Jo960178X  1
1996 Arterburn JB, Wu Y, Quintana W. Synth esis and characterization of a new isocyanato carborane anion [7-O=C=N-7-CB10H12]-; study on its reactivity toward amino containing compounds Polyhedron. 15: 4355-4359. DOI: 10.1016/0277-5387(96)00239-2  1
1996 Arterburn JB, Perry MC. Rhenium catalyzed sulfoxide reduction Tetrahedron Letters. 37: 7941-7944. DOI: 10.1016/0040-4039(96)01836-9  1
1996 Arterburn JB, Fogarty IM, Hall KA, Ott KC, Bryan JC. Functionalized organoimidorhenium(v) complexes as potential radiopharmaceuticals: Syntheses of glycine derivatives and the structure determination of a rhenium analogue of chlorambucil Angewandte Chemie - International Edition in English. 35: 2877-2979. DOI: 10.1002/Anie.199628771  1
1996 Arterburn JB, Fogarty IM, Hall KA, Ott KC, Bryan JC. Funktionalisierte Organoimidorhenium(V)-Komplexe als potentielle Radiopharmaka – die Synthese von Glycinderivaten und die strukturelle Charakterisierung eines Rheniumanalogons von Chlorambucil Angewandte Chemie. 108: 3039-3040. DOI: 10.1002/Ange.19961082342  0.01
1992 Mash EA, Arterburn JB, Nimkar SK. Synthesis of a mevinic acid lactone precursor Journal of Carbohydrate Chemistry. 11: 415-424. DOI: 10.1080/07328309208017803  1
1992 Bryan JC, Arterburn JB, Cook GK, Mayer JM. Deoxygenative coupling of ketones and alkenes by tungsten(II) compounds Organometallics. 11: 3965-3970. DOI: 10.1021/Om00060A010  1
1992 Bryan JC, Arterburn JB, Cook GK, Mayer JM. Deoxygenative coupling of ketones and alkenes by tungsten(II) compounds Organometallics. 11: 3965-3970. DOI: 10.1021/om00060a010  0.04
1992 Thorn KA, Arterburn JB, Mikita MA. Nitrogen-15 and carbon-13 NMR investigation of hydroxylamine-derivatized humic substances Environmental Science & Technology. 26: 107-116. DOI: 10.1021/es00025a011  0.01
1992 Thorn KA, Arterburn JB, Mikita MA. 15N and13C NMR investigation of hydroxylamine-derivatized humic substances Environmental Science and Technology. 26: 107-116.  1
1991 Mash EA, Arterburn JB. Enantiomerically pure acetals in organic synthesis. 3. A synthesis of (R)-mevalonic acid lactone Journal of Organic Chemistry. 56: 885-888. DOI: 10.1021/Jo00002A079  1
1991 Mash EA, Arterburn JB, Fryling JA, Mitchell SH. Enantiomerically pure acetals in organic synthesis. 1. Chromatographic separability of furanoside and pyranoside acetals derived from α-hydroxy esters Journal of Organic Chemistry. 56: 1088-1093.  1
1989 Mash EA, Math SK, Arterburn JB. Homochiral ketals in organic synthesis. Diastereoselective cyclopropanation of medium and large ring α,α-unsaturated ketals derived from 1,4-di-O-benzyl-L-threitol Journal of Organic Chemistry. 54: 4951-4953. DOI: 10.1021/Jo00281A044  1
1989 Mash EA, Arterburn JB, Fryling JA. Homochiral acetals in organic synthesis. A general enantioselective entry to carbohydrate derivatives from non-carbohydrate precursors Tetrahedron Letters. 30: 7145-7148. DOI: 10.1016/S0040-4039(01)93919-X  1
1989 Thorn KA, Folan DW, Arterburn JB, Mikita MA, MacCarthy P. Application of INEPT nitrogen-15 and silicon-29 nuclear magnetic resonance spectrometry to derivatized fulvic acids Science of the Total Environment, The. 81: 209-218. DOI: 10.1016/0048-9697(89)90127-7  1
1986 Thorn KA, Arterburn JB, Mikita MA. **1**5N-NMR INVESTIGATION OF HYDROXYLAMINE DERIVATIZED HUMIC SUBSTANCES National Meeting - American Chemical Society, Division of Environmental Chemistry. 26: 153-155.  1
Show low-probability matches.